Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 299
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03720041 | Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT00005056 | Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | ||
| NCT03024580 | A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | ||
| NCT05722886 | DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol | ||
| NCT05877352 | Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial | ||
| NCT00027664 | Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer | ||
| NCT03728881 | Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial | ||
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer | ||
| NCT00678327 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | ||
| NCT00758173 | Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom | ||
| NCT00427713 | Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer | ||
| NCT04307576 | A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | ||
| NCT05097625 | Head and Neck Early Relapse Detection Study (HERD) | ||
| NCT00532194 | An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer | ||
| NCT05611632 | Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical Trial | ||
| NCT01460888 | Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus | ||
| NCT00829205 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | ||
| NCT05408169 | Increasing Uptake of Bowel Screening | ||
| NCT04478929 | Early Detection of Barrett's Esophagus Through Deep Image Retrieval | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT02688257 | Assessing Treatment Response in Breast Cancer With Functional Imaging | ||
| NCT01679119 | Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy | ||
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT02960620 | Therasphere for Unresectable Primary or Secondary Liver Neoplasia | ||
| NCT01279967 | A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma | ||
| NCT02761915 | A Phase I Trial of Anti-GD2 T-cells (1RG-CART) | ||
| NCT01937533 | Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer | ||
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT00080912 | Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases | ||
| NCT02768337 | Cambridge Brain Mets Trial 1 | ||
| NCT00757991 | Blood Samples From Healthy Volunteers for Genetic Studies in the East Anglia Region of the United Kingdom | ||
| NCT02308072 | Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer | ||
| NCT00032175 | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT04717674 | [18F]FPIA PET/CT Imaging in Patients With Solid Tumours | ||
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer | ||
| NCT02866370 | Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium | ||
| NCT03916510 | Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | ||
| NCT02051868 | International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel | ||
| NCT02544308 | Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma | ||
| NCT01719835 | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study | ||
| NCT01431664 | AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia | ||
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors | ||
| NCT01737255 | Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome | ||
| NCT02024009 | Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | ||
| NCT03307148 | Stromal TARgeting for PAncreatic Cancer (STAR_PAC) | ||
| NCT01874171 | Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC | ||
| NCT04161417 | Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer | ||
| NCT02417662 | Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer | ||
| NCT00989105 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | ||
| NCT00112931 | Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma |
